{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:17:06Z","timestamp":1793456226634,"version":"4.5.0"},"reference-count":198,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012318","name":"Ernest S Bazley Residuary Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug molecules and form complexes with them that activate mast cells. However, in recent years another mechanism has been proposed, in which some drugs closely associated with allergic-type events can bypass the antibody-mediated pathway and trigger mast cell degranulation directly by activating a mast cell-specific receptor called Mas-related G protein-coupled receptor X2 (MRGPRX2). This would result in symptoms similar to IgE-mediated events, but would not require immune priming. This review will cover the frequency, severity, and dose-responsiveness of allergic-type events for several drugs shown to have MRGPRX2 agonist activity. Surprisingly, the analysis shows that mild-to-moderate events are far more common than currently appreciated. A comparison with plasma drug levels suggests that MRGPRX2 mediates many of these mild-to-moderate events. For some of these drugs, then, MRGPRX2 activation may be considered a regular and predictable feature after administration of high doses.<\/jats:p>","DOI":"10.3389\/fimmu.2021.676354","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T01:28:58Z","timestamp":1628213338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":111,"title":["MRGPRX2 and Adverse Drug Reactions"],"prefix":"10.3389","volume":"12","author":[{"given":"Benjamin D.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"B1","article-title":"Adverse Drug Reactions: Types and Treatment Options","volume":"68","author":"Riedl","year":"2003","journal-title":"Am Fam Physician"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.01.031","article-title":"Molecular Mechanisms and Pathophysiology of Perioperative Hypersensitivity and Anaphylaxis: A Narrative Review","volume":"123","author":"Ebo","year":"2019","journal-title":"Br J Anaesthesia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.04.001","article-title":"Anaesthesia, Surgery, and Life-Threatening Allergic Reactions: Protocol and Methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists","volume":"121","author":"Cook","year":"2018","journal-title":"Br J Anaesthesia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000857","article-title":"Perioperative Anaphylaxis: Diagnostic Challenges and Management","volume":"33","author":"Savic","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.09.003","article-title":"Drug Hypersensitivity Reactions","volume":"104","author":"Dykewicz","year":"2020","journal-title":"Med Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"Ige and Mast Cells in Allergic Disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the Human Mast Cell Transcriptome by Deep-CAGE Sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.08.177","article-title":"Immunoglobulin E-Independent Activation of Mast Cell Is Mediated by Mrg Receptors","volume":"349","author":"Tatemoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz951","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2020: Extending Immunopharmacology Content and Introducing the IUPHAR\/MMV Guide to MALARIA PHARMACOLOGY","volume":"48","author":"Armstrong","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302456200","article-title":"MrgX2 Is a High Potency Cortistatin Receptor Expressed in Dorsal Root Ganglion","volume":"278","author":"Robas","year":"2003","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.088","article-title":"Identification of MrgX2 as a Human G-Protein-Coupled Receptor for Proadrenomedullin N-Terminal Peptides","volume":"330","author":"Kamohara","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature14022","article-title":"Identification of a Mast-Cell-Specific Receptor Crucial for Pseudo-Allergic Drug Reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2334","article-title":"In Silico Design of Novel Probes for the Atypical Opioid Receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a Promiscuous Receptor for Basic Peptides Causing Mast Cell Pseudo-Allergic and Anaphylactoid Reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"B15","doi-asserted-by":"publisher","first-page":"135746","DOI":"10.1016\/j.neulet.2021.135746","article-title":"Minireview: Mas-Related G Protein-Coupled Receptor X2 Activation by Therapeutic Drugs","volume":"751","author":"McNeil","year":"2021","journal-title":"Neurosci Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2018.08.005","article-title":"Mivacurium Induce Mast Cell Activation and Pseudo-Allergic Reactions via MAS-Related G Protein Coupled Receptor-X2","volume":"332","author":"Che","year":"2018","journal-title":"Cell Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.07.020","article-title":"Cisatracurium Induces Mast Cell Activation and Pseudo-Allergic Reactions via MRGPRX2","volume":"62","author":"Che","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801423","article-title":"A Mast Cell\u2013Specific Receptor Is Critical for Granuloma Induced by Intrathecal Morphine Infusion","volume":"203","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5897\/JCAB.9000111","article-title":"Morphine Is an Exogenous Ligand for MrgX2, a G Protein-Coupled Receptor for Cortistatin","volume":"3","author":"Akuzawa","year":"2009","journal-title":"J Cell Anim Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85538","article-title":"Different Activation Signals Induce Distinct Mast Cell Degranulation Strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13509","article-title":"Gpcrdb: The G Protein-Coupled Receptor Database - An Introduction","volume":"173","author":"Munk","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human \u03b2-Defensin-3, and Icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.3390\/ijms20215247","article-title":"Identification of Gain and Loss of Function Missense Variants in MRGPRX2\u2019s Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P","volume":"20","author":"Chompunud Na Ayudhya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 Activation Causes Increased Skin Reactivity in Patients With Chronic Spontaneous Urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100080","DOI":"10.1016\/j.waojou.2019.100080","article-title":"Ige Allergy Diagnostics and Other Relevant Tests in Allergy, a World Allergy Organization Position Paper","volume":"13","author":"Ansotegui","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/all.14603","article-title":"Advances and Novel Developments in Drug Hypersensitivity Diagnosis","volume":"75","author":"Ariza","year":"2020","journal-title":"Allergy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0176-x","article-title":"In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations","volume":"17","author":"Decuyper","year":"2017","journal-title":"Drugs R&D"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/all.12142","article-title":"Skin Test Concentrations for Systemically Administered Drugs - An ENDA\/EAACI Drug Allergy Interest Group Position Paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jaip.2018.09.034","article-title":"Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir034","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000665","article-title":"Adverse Reactions to Vancomycin and Cross-Reactivity With Other Antibiotics","volume":"20","author":"De Luca","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31824e10d7","article-title":"Defining Risk Factors for Red Man Syndrome in Children and Adults","volume":"31","author":"Myers","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/pharmacy8020070","article-title":"Glycopeptide Hypersensitivity and Adverse Reactions","volume":"8","author":"Huang","year":"2020","journal-title":"Pharmacy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jac\/27.suppl_B.17","article-title":"Anaphylactoid Reactions to Glycopeptide Antibiotics","volume":"27","author":"Polk","year":"1991","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198707000-00026","article-title":"Histamine Release by Vancomycin: A Mechanism for Hypotension in Man","volume":"67","author":"Levy","year":"1987","journal-title":"Anesthesiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.3.502","article-title":"Vancomycin and the Red-Man Syndrome: Pharmacodynamics of Histamine Release","volume":"157","author":"Polk","year":"1988","journal-title":"J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.4.550","article-title":"Vancomycin-Induced Histamine Release and \u201cRed Man Syndrome\u201d: Comparison of 1- and 2-Hour Infusions","volume":"34","author":"Healy","year":"1990","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.5.765","article-title":"Comparison of Vancomycin- and Teicoplanin-Induced Histamine Release and \u201cRed Man Syndrome\u201d","volume":"34","author":"Sahai","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s000110050279","article-title":"Histamine Release During Rapid Vancomycin Administration","volume":"47","author":"Renz","year":"1998","journal-title":"Inflammation Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.5.876","article-title":"Influence of Antihistamine Pretreatment on Vancomycin-Induced Red-Man Syndrome","volume":"160","author":"Sahai","year":"1989","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.6.1180","article-title":"Red Man Syndrome: Incidence, Etiology, and Prophylaxis","volume":"164","author":"Wallace","year":"1991","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199809000-00036","article-title":"Oral Antihistamines Reduce the Side Effects From Rapid Vancomycin Infusion","volume":"87","author":"Renz","year":"1998","journal-title":"Anesth Analg"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199909000-00006","article-title":"Antihistamine Prophylaxis Permits Rapid Vancomycin Infusion","volume":"27","author":"Renz","year":"1999","journal-title":"Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199809000-00010","article-title":"Tryptase Levels Are Not Increased During Vancomycin-Induced Anaphylactoid Reactions","volume":"89","author":"Renz","year":"1998","journal-title":"Anesthesiology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-09","article-title":"Comparative Efficacy and Safety of Vancomycin Versus Teicoplanin: Systematic Review and Meta-Analysis","volume":"53","author":"Svetitsky","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jac.a020861","article-title":"Risk Factors for Adverse Cutaneous Reactions Associated With Intravenous Vancomycin","volume":"39","author":"Korman","year":"1997","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of \u201cRed Man Syndrome\u201d in Patients Being Treated With Vancomycin or High-Dose Teicoplanin","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.3.773","article-title":"Prospective Evaluation of Red Man Syndrome in Patients Receiving Vancomycin","volume":"168","author":"O\u2019Sullivan","year":"1993","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1756-0500-4-236","article-title":"The Study of Vancomycin Use and Its Adverse Reactions Associated to Patients of a Brazilian University Hospital","volume":"4","author":"Marinho","year":"2011","journal-title":"BMC Res Notes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/archinte.1989.00390080053013","article-title":"Mild Nephrotoxicity Associated With Vancomycin Use","volume":"149","author":"Downs","year":"1989","journal-title":"Arch Internal Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-30","article-title":"Gram-Positive Infections and the Use of Vancomycin in 550 Episodes of Fever and Neutropenia","volume":"108","author":"Rubin","year":"1988","journal-title":"Ann Intern Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.027","article-title":"Vancomycin Hypersensitivity Reactions Documented in Electronic Health Records","volume":"9","author":"Alvarez-Arango","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.3.393","article-title":"Comparison of Steady-State Pharmacokinetics of Two Dosage Regimens of Vancomycin in Normal Volunteers","volume":"31","author":"Healy","year":"1987","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin Skin Tests and Prediction of \u201cRed Man Syndrome\u201d in Healthy Volunteers","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.1.92","article-title":"Pharmacokinetics and Serum Bactericidal Activity of Vancomycin Alone and in Combination With Ceftazidime in Healthy Volunteers","volume":"32","author":"Boeckh","year":"1988","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archpedi.1984.02140390009004","article-title":"Adverse Reactions to Vancomycin Used as Prophylaxis for CSF Shunt Procedures","volume":"138","author":"Odio","year":"1984","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2015.06.024","article-title":"The Role of Mast Cells in Bacterial Infection","volume":"186","author":"Johnzon","year":"2016","journal-title":"Am J Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/87.5.755","article-title":"Structure, Conformation, and Action of Neuromuscular Blocking Drugs \u2020","volume":"87","author":"Lee","year":"2001","journal-title":"Br J Anaesthesia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2044.2008.05866.x","article-title":"The Undesirable Effects of Neuromuscular Blocking Drugs","volume":"64","author":"Claudius","year":"2009","journal-title":"Anaesthesia"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199753050-00012","article-title":"Cisatracurium Besilate","volume":"53","author":"Bryson","year":"1997","journal-title":"Drugs"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199511000-00020","article-title":"A Two-Center Comparison of the Cardiovascular Effects of Cisatracurium (Nimbex Trademmark) and Vecuronium in Patients With Coronary Artery Disease","volume":"81","author":"Konstadt","year":"1995","journal-title":"Anesthesia Analgesia"},{"key":"B64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/bja\/53.1.31","article-title":"The Pharmacology of Atracurium: A New Competitive Neuromuscular Blocking Agent","volume":"53","author":"Hughes","year":"1981","journal-title":"Br J Anaesthesia"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/58.8.834","article-title":"Clinical Pharmacology of Atracurium Given in High Dose","volume":"58","author":"Scott","year":"1986","journal-title":"Br J Anaesth"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.6.550","article-title":"Atracurium: Clinical Strategies for Preventing Histamine Release and Attenuating the Haemodynamic Response","volume":"57","author":"Scott","year":"1985","journal-title":"Br J Anaesth"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198867110-00012","article-title":"Combined H1 and H2 Receptor Blockade Attenuates the Cardiovascular Effects of High-Dose Atracurium for Rapid Sequence Endotracheal Intubation","volume":"67","author":"Hosking","year":"1988","journal-title":"Anesth Analg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/68.2.155","article-title":"The Role of Histamine in the Cardiovascular Effects of Atracurium","volume":"68","author":"Adt","year":"1992","journal-title":"Br J Anaesthesia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"967???972","DOI":"10.1213\/00000539-199405000-00023","article-title":"Are Hypotension and Rash After Atracurium Really Caused by Histamine Release","volume":"78","author":"Doenicke","year":"1994","journal-title":"Anesthesia Analgesia"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198903000-00003","article-title":"The Cardiovascular Effects of Mivacurium Chloride (BW B1090U) in Patients Receiving Nitrous Oxide-Opiate-Barbiturate Anesthesia","volume":"70","author":"Savarese","year":"1989","journal-title":"Anesthesiology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199606000-00012","article-title":"The Neuromuscular Effects of Mivacurium Chloride During Propofol Anesthesia in Children","volume":"82","author":"Shorten","year":"1996","journal-title":"Anesth Analg"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12305","article-title":"Effects of Promethazine or Dexamethasone Pretreatment on Mivacurium-Induced Histamine Release in Children","volume":"24","author":"Xiang","year":"2014","journal-title":"Pediatr Anesthesia"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/75.5.588","article-title":"Histamine-Release Haemodynamic Changes Produced by Rocuronium, Vecuronium, Mivacurium, Atracurium and Tubocurarine","volume":"75","author":"Naguib","year":"1995","journal-title":"Br J Anaesthesia"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/BF03012575","article-title":"Age Related Variability in the Effects of Mivacurium in Paediatric Surgical Patients","volume":"45","author":"Brandom","year":"1998","journal-title":"Can J Anaesthesia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199912000-00016","article-title":"Evaluation of Neuromuscular and Cardiovascular Effects of Two Doses of Rapacuronium (ORG 9487) Versus Mivacurium and Succinylcholine","volume":"91","author":"Miguel","year":"1999","journal-title":"Anesthesiology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198902000-00009","article-title":"Clinical Pharmacology of Mivacurium Chloride (BW B1090U) in Children During Nitrous Oxide-Halothane and Nitrous Oxide-Narcotic Anesthesia","volume":"68","author":"Sarner","year":"1989","journal-title":"Anesthesia Analgesia"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/0952-8180(96)85617-0","article-title":"Efficacy and Safety of Divided Dose Administration of Mivacurium for a 90-Second Tracheal Intubation","volume":"8","author":"Ali","year":"1996","journal-title":"J Clin Anesthesia"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/77.3.421","article-title":"Effect of Oral Antihistamine Premedication on Mivacurium-Induced Histamine Release and Side Effects","volume":"77","author":"Doenicke","year":"1996","journal-title":"Br J Anaesthesia"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/74.3.330","article-title":"Comparison of the Haemodynamic Effects of Mivacurium and Atracurium During Fentanyl Anaesthesia","volume":"74","author":"Loan","year":"1995","journal-title":"Br J Anaesthesia"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-200208000-00025","article-title":"The Cardiovascular Effects of Mivacurium in Hypertensive Patients","volume":"95","author":"Plaud","year":"2002","journal-title":"Anesth Analg"},{"key":"B81","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.annfar.2007.04.002","article-title":"Les R\u00e9actions Cutan\u00e9es Cons\u00e9cutives \u00c0\u00a0L\u2019induction Anesth\u00e9sique Au\u00a0Mivacurium","volume":"26","author":"Miloudi","year":"2007","journal-title":"Annales Fran\u00e7aises d\u2019Anesth\u00e9sie R\u00e9animation"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198903000-00028","article-title":"Hemodynamic Effects of Mivacurium Chloride Administered to Patients During Oxygen-Sufentanil Anesthesia for Coronary Artery Bypass Grafting or Valve Replacement","volume":"68","author":"Stoops","year":"1989","journal-title":"Anesth Analg"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X9802600508","article-title":"Mivacurium Compared With Three Different Doses of Suxamethonium for Nasotracheal Intubation","volume":"26","author":"Hodgson","year":"1998","journal-title":"Anaesthesia Intensive Care"},{"key":"B84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12871-017-0350-2","article-title":"The Efficacy and Safety of Mivacurium in Pediatric Patients","volume":"17","author":"Zeng","year":"2017","journal-title":"BMC Anesthesiology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/BF03012152","article-title":"Comparison of the Cardiovascular Effects of Cisatracurium and Vecuronium in Patients With Coronary Artery Disease","volume":"45","author":"Reich","year":"1998","journal-title":"Can J Anaesthesia"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199610000-00030","article-title":"Pharmacodynamic Dose-Response and Safety Study of Cisatracurium (51W89) in Adult Surgical Patients During N2O-O2-Opioid Anesthesia","volume":"83","author":"Lepage","year":"1996","journal-title":"Anesth Analg"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199703000-00030","article-title":"The Lack of Histamine Release With Cisatracurium: A Double-Blind Comparison With Vecuronium","volume":"84","author":"Doenicke","year":"1997","journal-title":"Anesth Analg"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199808000-00038","article-title":"Endotracheal Intubating Conditions, and Plasma Histamine After Cisatracurium and Vecuronium Administration","volume":"87","author":"Doenicke","year":"1998","journal-title":"Anesth Analg"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199505000-00007","article-title":"The Cardiovascular Effects and Histamine-Releasing Properties of 51W89 in Patients Receiving Nitrous Oxide\/Opioid\/Barbiturate Anesthesia","volume":"82","author":"Lien","year":"1995","journal-title":"Anesthesiology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, Surgery, and Life-Threatening Allergic Reactions: Epidemiology and Clinical Features of Perioperative Anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesthesia"},{"key":"B91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/ALN.0000000000000512","article-title":"Anaphylaxis is More Common With Rocuronium and Succinylcholine Than With Atracurium","volume":"122","author":"Reddy","year":"2015","journal-title":"Anesthesiology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/all.13456","article-title":"Neuromuscular Blocking Agents Induced Anaphylaxis: Results and Trends of a French Pharmacovigilance Survey From 2000 to 2012","volume":"73","author":"Petitpain","year":"2018","journal-title":"Allergy"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia From 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br J Anaesthesia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/63.6.661","article-title":"Pharmacokinetics of Atracurium and Laudanosine in the Elderly","volume":"63","author":"Kent","year":"1989","journal-title":"Br J Anaesthesia"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/55.2.113","article-title":"Pharmacokinetics of Atracurium Besylate in Healthy Patients (After a Single I.V. Bolus Dose)","volume":"55","author":"Ward","year":"1983","journal-title":"Br J Anaesthesia"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/BF01988720","article-title":"Wheal and Flare Responses to Muscl Relaxants in Humans","volume":"34","author":"Levy","year":"1991","journal-title":"Agents Actions"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200506000-00011","article-title":"Pharmacokinetics and Pharmacodynamics of Mivacurium in Patients Phenotypically Homozygous for the Atypical Plasma Cholinesterase Variant","volume":"102","author":"\u00d8stergaard","year":"2005","journal-title":"Anesthesiology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199702000-00008","article-title":"Pharmacokinetics of Mivacurium Isomers and Their Metabolites in Healthy Volunteers After Intravenous Bolus Administration","volume":"86","author":"Lacroix","year":"1997","journal-title":"Anesthesiology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/69.6.580","article-title":"Pharmacokinetics of Mivacurium N Normal Patients and in Those With Hepatic or Renal Failure","volume":"69","author":"Cook","year":"1992","journal-title":"Br J Anaesthesia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199406000-00017","article-title":"The Phamtacokinetics and Pharmacodynamics of the Stereoisomers of Mivacurium in Patients Receiving Nitrous Oxide\/Opioid\/Barbiturate Anesthesia","volume":"80","author":"Lien","year":"1994","journal-title":"Anesthesiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2002.460507.x","article-title":"The Pharmacodynamics and Pharmacokinetics of Mivacurium in Children","volume":"46","author":"\u00d8stergaard","year":"2002","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/76.5.624","article-title":"Pharmacokinetics and Pharmacodynamics of Cisatracurium in Patients With End-Stage Liver Disease Undergoing Liver Transplantation","volume":"76","author":"De Wolf","year":"1996","journal-title":"Br J Anaesthesia"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199611000-00029","article-title":"Importance of the Organ-Independent Elimination of Cisatracurium","volume":"83","author":"Kisor","year":"1996","journal-title":"Anesth Analg"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.6.844","article-title":"Weal and Flare Responses to Intradermal Rocuronium and Cisatracurium in Humans","volume":"85","author":"Levy","year":"2000","journal-title":"Br J Anaesthesia"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00093.x","article-title":"Rocuronium and Cisatracurium-Positive Skin Tests in non-Allergic Volunteers: Determination of Drug Concentration Thresholds Using a Dilution Titration Technique*","volume":"47","author":"Berg","year":"2003","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161070-00003","article-title":"Newer Neuromuscular Blocking Agents","volume":"61","author":"Sparr","year":"2001","journal-title":"Drugs"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200604000-00009","article-title":"Reversal of Rocuronium-Induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex","volume":"104","author":"Sorgenfrei","year":"2006","journal-title":"Anesthesiology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1991.tb09539.x","article-title":"The Neuromuscular Blocking Effect of Org 9426","volume":"46","author":"Booij","year":"1991","journal-title":"Anaesthesia"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/BF03013252","article-title":"Haemodynamic Effects of Rocuronium Bromide in Adult Cardiac Surgical Patients","volume":"45","author":"Hudson","year":"1998","journal-title":"Can J Anaesthesia"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/77.5.607","article-title":"Effects of Rocuronium and Vecuronium on Intracranial Pressure, Mean Arterial Pressure and Heart Rate in Neurosurgical Patients","volume":"77","author":"Schramm","year":"1996","journal-title":"Br J Anaesthesia"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/BF03009764","article-title":"Haemodynamic Effects of Rocuronium During Fentanyl Anaesthesia: Comparison With Vecuronium","volume":"40","author":"McCoy","year":"1993","journal-title":"Can J Anaesthesia"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002027","article-title":"Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient","volume":"44","author":"Murray","year":"2016","journal-title":"Crit Care Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199402000-00020","article-title":"Determination of the Hemodynamics and Histamine Release of Rocuronium (Org 9426) When Administered in Increased Doses Under N2O\/O2-Sufentanil Anesthesia","volume":"78","author":"Levy","year":"1994","journal-title":"Anesth Analg"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-015-2105-x","article-title":"Sugammadex and Rocuronium-Induced Anaphylaxis","volume":"30","author":"Takazawa","year":"2016","journal-title":"J Anesthesia"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000082993.84883.7D","article-title":"Anaphylaxis During the Perioperative Period","volume":"97","author":"Hepner","year":"2003","journal-title":"Anesthesia Analgesia"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bja.a013365","article-title":"Histaminoid Reactions Associated With Rocuronium","volume":"84","author":"Neal","year":"2000","journal-title":"Br J Anaesthesia"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.5152\/TJAR.2013.35","article-title":"Comparison of the Effect of Different Concentrations of Rocuronium on Injection Pain and Haemodynamics Using Isolated Forearm Technique","volume":"41","author":"Erbabacan","year":"2013","journal-title":"Turkish J Anesthesia Reanimation"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/79.3.382","article-title":"Spontaneous Movements Associated With Rocuronium: Is Pain on Injection the Cause","volume":"79","author":"Borgeat","year":"1997","journal-title":"Br J Anaesth"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200303000-00011","article-title":"Injection Pain of Rocuronium and Vecuronium is Evoked by Direct Activation of Nociceptive Nerve Endings","volume":"20","author":"Blunk","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2007.02.012","article-title":"Neutralized Rocuronium (Ph 7.4) Before Administration Prevents Injection Pain in Awake Patients: A Randomized Prospective Trial","volume":"19","author":"Han","year":"2007","journal-title":"J Clin Anesthesia"},{"key":"B121","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3346\/jkms.2009.24.5.879","article-title":"Antihistamine Pretreatment to Reduce Incidence of Withdrawal Movement After Rocuronium Injection","volume":"24","author":"Lee","year":"2009","journal-title":"J Korean Med Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/BF00548406","article-title":"Pharmacokinetics of Chlorpheniramine After Intravenous and Oral Administration in Normal Adults","volume":"22","author":"Huang","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/BF03007578","article-title":"The Pharmacodynamics and Pharmacokinetics of Org 9426, A New Non-Depolarizing Neuromuscular Blocking Agent, in Patients Anaesthetized With Nitrous Oxide, Halothane and Fentanyl","volume":"38","author":"Wierda","year":"1991","journal-title":"Can J Anaesthesia"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199504000-00018","article-title":"The Pharmacokinetics and Neuromuscular Effects of Rocuronium Bromide in Patients With Liver Disease","volume":"80","author":"Magorian","year":"1995","journal-title":"Anesthesia Analgesia"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/71.2.222","article-title":"Time Course of Neuromuscular Effects and Pharmacokinetics of Rocuronium Bromide (Org 9426) During Isoflurane Anaesthesia in Patients With and Without Renal Failure","volume":"71","author":"Cooper","year":"1993","journal-title":"Br J Anaesth"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00653.x","article-title":"The Pharmacokinetics and Pharmacodynamics of Rocuronium in Patients With Hepatic Cirrhosis","volume":"44","author":"Van Miert","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/00000542-199211000-00010","article-title":"Pharmacokinetics of Rocuronium Bromide (ORG 9426) in Patients With Normal Renal Function or Patients Undergoing Cadaver Renal Transplantation","volume":"77","author":"Szenohradszky","year":"1992","journal-title":"Anesthesiology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199605000-00011","article-title":"Repeated Doses of Rocuronium Bromide Administered to Cirrhotic and Control Patients Receiving Isoflurane","volume":"84","author":"Servin","year":"1996","journal-title":"Anesthesiology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.05.046","article-title":"Association Between Mutated Mas-Related G Protein-Coupled Receptor-X2 and Rocuronium-Induced Intraoperative Anaphylaxis","volume":"125","author":"Suzuki","year":"2020","journal-title":"Br J Anaesth"},{"key":"B130","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 Activation by Rocuronium: Insights From Studies With Human Skin Mast Cells and Missense Variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-Releasing and Allergenic Properties of Opioid Analgesic Drugs: Resolving the Two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesthesia Intensive Care"},{"key":"B132","article-title":"Management of Common Opioid-Induced Adverse Effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"key":"B133","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s005200100274","article-title":"Morphine in Cancer Pain Management: A Practical Guide","volume":"10","author":"Donnelly","year":"2002","journal-title":"Supportive Care Cancer"},{"key":"B134","volume-title":"Meyler\u2019s Side Effects of Drugs","author":"Aronson","year":"2016"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-013-9989-4","article-title":"Butorphanol Prevents Morphine-Induced Pruritus Without Increasing Pain and Other Side Effects: A Systematic Review of Randomized Controlled Trials","volume":"60","author":"Du","year":"2013","journal-title":"Can J Anesthesia\/Journal canadien d\u2019anesth\u00e9sie"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90085-1","article-title":"Itching After Epidural and Spinal Opiates","volume":"33","author":"Ballantyne","year":"1988","journal-title":"Pain"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200106000-00002","article-title":"Pharmacological Control of Opioid-Induced Pruritus: A Quantitative Systematic Review of Randomized Trials","volume":"18","author":"Kjellberg","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.117045","article-title":"Neuraxial Opioid-Induced Pruritus: An Update","volume":"29","author":"Kumar","year":"2013","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei085","article-title":"Effects of Acetaminophen on Morphine Side-Effects and Consumption After Major Surgery: Meta-Analysis of Randomized Controlled Trials \u2020 \u2020Presented in Part at the Annual Meeting of the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019anesth\u00e9sie-R\u00e9animation, Paris, April 2004","volume":"94","author":"Remy","year":"2005","journal-title":"Br J Anaesthesia"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report","volume":"19","author":"Cherny","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1109","article-title":"Long-Acting Morphine for Pain Control in Paediatric Oncology","volume":"36","author":"Zernikow","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.08.043","article-title":"Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13009","article-title":"Relationship Between MRGPRX2 and Pethidine Hydrochloride- or Fentanyl Citrate-Induced LAD2 Cell Degranulation","volume":"70","author":"Liu","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000003887","article-title":"Side Effect Rates of Opioids in Equianalgesic Doses via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-Analysis","volume":"129","author":"Dinges","year":"2019","journal-title":"Anesth Analg"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2230.2009.03463.x","article-title":"Opioid-Induced Pruritus: An Update","volume":"35","author":"Reich","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198202000-00003","article-title":"Histamine Release During Morphine and Fentanyl Anesthesia","volume":"56","author":"Rosow","year":"1982","journal-title":"Anesthesiology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198109000-00019","article-title":"The Use of H1 and H2 Histamine Antagonists With Morphine Anesthesia: A Double-Blind Study","volume":"55","author":"Philbin","year":"1981","journal-title":"Anesthesiology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197306000-00007","article-title":"The Cardiovascular Effects of Morphine Sulfate With Oxygen and With Nitrous Oxide in Man","volume":"38","author":"Wong","year":"1973","journal-title":"Anesthesiology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00000542-197902000-00005","article-title":"Morphine Decreases Peripheral Vascular Resistance and Increases Capacitance in Man","volume":"50","author":"Hsu","year":"1979","journal-title":"Anesthesiology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.83","article-title":"Role of Histamine in the Hemodynamic and Plasma Catecholamine Responses to Morphine","volume":"33","author":"Fahmy","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(82)80005-5","article-title":"Effects of Infused Histamine: Correlation of Plasma Histamine Levels and Symptoms","volume":"69","author":"Kaliner","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03364.x","article-title":"Morphine Is an Arteriolar Vasodilator in Man","volume":"67","author":"Afshari","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(85)90813-9","article-title":"Skin Test Suppression by Antihistamines and the Development of Subsensitivity","volume":"76","author":"Long","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198905000-00008","article-title":"Wheal and Flare Responses to Opioids in Humans","volume":"70","author":"Levy","year":"1989","journal-title":"Anesthesiology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(85)90811-5","article-title":"The Development of Subsensitivity to Chlorpheniramine","volume":"76","author":"Taylor","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90447-0","article-title":"Induction of Human Cutaneous Mast Cell Degranulation by Opiates and Endogenous Opioid Peptides: Evidence for Opiate and Nonopiate Receptor Participation","volume":"73","author":"Casale","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.51.30290","article-title":"Presence of the \u03bc3Opiate Receptor in Endothelial Cells","volume":"270","author":"Stefano","year":"1995","journal-title":"J Biol Chem"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.189","article-title":"Morphine-Induced Skin Wheals: A Possible Model for the Study of Histamine Release","volume":"38","author":"Saucedo","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"B159","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1747-597X-9-12","article-title":"Risk of Anaphylaxis in Opioid Dependent Persons: Effects of Heroin Versus Substitution Substance","volume":"9","author":"Maurer","year":"2014","journal-title":"Subst Abuse Treatment Prevention Policy"},{"key":"B160","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak Plasma Concentrations After Oral Morphine","volume":"16","author":"Collins","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.4.903","article-title":"Pharmacokinetics of Morphine and its Glucuronides Following Intravenous Administration of Morphine in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis","volume":"14","author":"Pauli-Magnus","year":"1999","journal-title":"Nephrol Dialysis Transplant"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.42","article-title":"The Metabolite Morphine-6-Glucuronide Contributes to the Analgesia Produced by Morphine Infusion in Patients With Pain and Normal Renal Function","volume":"51","author":"Portenoy","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0329-x","article-title":"Serum and Cerebrospinal Fluid Morphine Pharmacokinetics After Single Doses of Intravenous and Intramuscular Morphine After Hip Replacement Surgery","volume":"63","author":"Dale","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2001.01369.x","article-title":"Lack of Effect of Ondansetron on the Pharmacokinetics and Analgesic Effects of Morphine and Metabolites After Single-Dose Morphine Administration in Healthy Volunteers","volume":"51","author":"Crews","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200009000-00009","article-title":"Pharmacokinetics and Pharmacodynamics of Inhaled Versus Intravenous Morphine in Healthy Volunteers","volume":"93","author":"Dershwitz","year":"2000","journal-title":"Anesthesiology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1177\/000456328702400205","article-title":"Analysis of Morphine and its Major Metabolites by Differential Radioimmunoassay","volume":"24","author":"Hand","year":"1987","journal-title":"Ann Clin Biochem: Int J Lab Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone Antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-03267-5","article-title":"When Antibiotics Turn Toxic","volume":"555","author":"Marchant","year":"2018","journal-title":"Nature"},{"key":"B169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00003495-199958002-00007","article-title":"Toxicity of Quinolones","volume":"58","author":"Stahlmann","year":"1999","journal-title":"Drugs"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1086\/428055","article-title":"Antimicrobial Safety: Focus on Fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B171","year":"2018"},{"key":"B172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmacy7030097","article-title":"Quinolone Allergy","volume":"7","author":"McGee","year":"2019","journal-title":"Pharmacy"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2019.247","article-title":"Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals","volume":"40","author":"Yarrington","year":"2019","journal-title":"Infection Control Hosp Epidemiol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90170-1","article-title":"Safety Profile of Oral and Intravenous Moxifloxacin: Cumulative Data From Clinical Trials and Postmarketing Studies","volume":"26","author":"Ball","year":"2004","journal-title":"Clin Ther"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0650","article-title":"Drug-Induced Pruritus: A Review","volume":"89","author":"Reich","year":"2009","journal-title":"Acta Dermato Venereologica"},{"key":"B176","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11255-017-1507-0","article-title":"Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis by Short-Course Intravenous Levofloxacin (750\u00a0Mg\/Day) or Conventional Intravenous\/Oral Levofloxacin (500\u00a0Mg\/Day): Prospective, Open-Label, Randomized, Controlled, Multicenter, non-I","volume":"49","author":"Ren","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.SD.187","article-title":"Ciprofloxacin: An Overview of Adverse Experiences","author":"Ball","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3724-3730.2002","article-title":"Target Site Concentrations of Ciprofloxacin After Single Intravenous and Oral Doses","volume":"46","author":"Brunner","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-018-0613-0","article-title":"Prevalence and Characteristics of Hospital Inpatients With Reported Fluoroquinolone Allergy","volume":"40","author":"Wall","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"B180","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbadis.2011.03.016","article-title":"Intestinal Mast Cells in Gut Inflammation and Motility Disturbances","volume":"1822","author":"De Winter","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/cells9051134","article-title":"Do Mast Cells Have a Role in Tendon Healing and Inflammation","volume":"9","author":"Alim","year":"2020","journal-title":"Cells"},{"key":"B182","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/ar4374","article-title":"Mast Cells Exert Pro-Inflammatory Effects of Relevance to the Pathophyisology of Tendinopathy","volume":"15","author":"Behzad","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02713-1","article-title":"Fluoroquinolones and the Risk of Tendon Injury: A Systematic Review and Meta-Analysis","volume":"75","author":"Alves","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730080-00007","article-title":"Incidence of Allergic Reactions Associated With Antibacterial Use in a Large, Managed Care Organisation","volume":"30","author":"Johannes","year":"2007","journal-title":"Drug Saf"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140030-00003","article-title":"Comparative Pharmacokinetics and Pharmacodynamics of the Newer Fluoroquinolone Antibacterials","volume":"40","author":"Aminimanizani","year":"2001","journal-title":"Clin Pharmacokinetics"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0661-6","article-title":"A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life","volume":"57","author":"Schlender","year":"2018","journal-title":"Clin Pharmacokinetics"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732020-00002","article-title":"The Clinical Pharmacokinetics of Levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clin Pharmacokinetics"},{"key":"B188","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/AAC.34.3.398","article-title":"Penetration of Ciprofloxacin Into Heart Valves, Myocardium, Mediastinal Fat, and Sternal Bone Marrow in Humans","volume":"34","author":"Mertes","year":"1990","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.4.1114","article-title":"Steady-State Plasma and Intrapulmonary Concentrations of Levofloxacin and Ciprofloxacin in Healthy Adult Subjects","volume":"119","author":"Gotfried","year":"2001","journal-title":"Chest"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg035","article-title":"Pharmacokinetic Aspects of Levofloxacin 500 Mg Once Daily During Sequential Intravenous\/Oral Therapy in Patients With Lower Respiratory Tract Infections","volume":"51","author":"Furlanut","year":"2003","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.2122-2125.2001","article-title":"Safety and Pharmacokinetics of Multiple 750-Milligram Doses of Intravenous Levofloxacin in Healthy Volunteers","volume":"45","author":"Chow","year":"2001","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B192","volume-title":"Statpearls","author":"Yan","year":"2020"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.16.233S.33992","article-title":"Pharmacokinetics and Pharmacodynamics of Fluoroquinolones","volume":"21","author":"Rodvold","year":"2001","journal-title":"Pharmacotherapy"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.09.009","article-title":"Enhanced Distribution of Fourth-Generation Fluoroquinolones in Prostatic Tissue","volume":"33","author":"Perletti","year":"2009","journal-title":"Int J Antimicrobial Agents"},{"key":"B195","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00133-06","article-title":"Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid","volume":"52","author":"Kiem","year":"2008","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.835","article-title":"Concentrations of Moxifloxacin in Serum and Pulmonary Compartments Following a Single 400 Mg Oral Dose in Patients Undergoing Fibre-Optic Bronchoscopy","volume":"44","author":"Soman","year":"1999","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1293\/tox.21.123","article-title":"Chondrotoxicity of Quinolone Antimicrobial Agents","volume":"21","author":"Kato","year":"2008","journal-title":"J Toxicol Pathol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2010.10.003","article-title":"Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population","volume":"3","author":"Hall","year":"2011","journal-title":"PM&R"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T01:29:03Z","timestamp":1628213343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.676354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":198,"alternative-id":["10.3389\/fimmu.2021.676354"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.676354","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"article-number":"676354"}}